Per Omvik

12.2k total citations · 2 hit papers
125 papers, 8.7k citations indexed

About

Per Omvik is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Per Omvik has authored 125 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Cardiology and Cardiovascular Medicine, 30 papers in Complementary and alternative medicine and 25 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Per Omvik's work include Blood Pressure and Hypertension Studies (82 papers), Heart Rate Variability and Autonomic Control (35 papers) and Cardiovascular and exercise physiology (30 papers). Per Omvik is often cited by papers focused on Blood Pressure and Hypertension Studies (82 papers), Heart Rate Variability and Autonomic Control (35 papers) and Cardiovascular and exercise physiology (30 papers). Per Omvik collaborates with scholars based in Norway, United States and Sweden. Per Omvik's co-authors include Sverre E. Kjeldsen, Stevo Julius, Markku S. Nieminen, Lars Lindholm, Hans Ibsen, Richard B. Devereux, Ole Lederballe‐Pedersen, Frej Fyhrquist, Ulf dé Fairé and Hans Wedel and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Per Omvik

123 papers receiving 8.1k citations

Hit Papers

Cardiovascular morbidity and mortality in the Losartan In... 2002 2026 2010 2018 2002 2002 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
    2002 3.9k citations Richard B. Devereux, Sverre E. Kjeldsen et al. profile →
  2. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
    2002 1.1k citations Lars Lindholm, Hans Ibsen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Omvik Norway 27 6.8k 3.1k 1.1k 958 952 125 8.7k
Björn Dahlöf Sweden 41 8.6k 1.3× 3.0k 1.0× 1.5k 1.4× 962 1.0× 941 1.0× 94 10.7k
Ole Lederballe‐Pedersen United States 16 5.4k 0.8× 2.7k 0.9× 811 0.8× 857 0.9× 694 0.7× 23 6.8k
W. H. Birkenhäger Netherlands 30 4.6k 0.7× 1.9k 0.6× 726 0.7× 559 0.6× 897 0.9× 100 6.6k
Joël Ménard France 35 5.7k 0.8× 3.2k 1.0× 1.6k 1.4× 384 0.4× 769 0.8× 143 9.4k
Vasilios Papademetriou United States 54 7.2k 1.1× 2.5k 0.8× 1.8k 1.7× 689 0.7× 908 1.0× 300 10.4k
Gastone Leonetti Italy 39 5.5k 0.8× 1.8k 0.6× 935 0.9× 510 0.5× 840 0.9× 197 7.0k
Dag Elmfeldt Sweden 35 7.1k 1.0× 3.0k 0.9× 1.4k 1.3× 386 0.4× 824 0.9× 94 9.3k
Enrico Agabiti‐Rosei Italy 46 5.5k 0.8× 2.3k 0.7× 1.7k 1.5× 555 0.6× 592 0.6× 221 8.3k
Carlo Porcellati Italy 41 7.9k 1.2× 1.6k 0.5× 1.6k 1.5× 783 0.8× 751 0.8× 90 9.5k
Björn Dahlöf Sweden 40 8.8k 1.3× 4.3k 1.4× 3.1k 2.8× 527 0.6× 922 1.0× 104 12.0k

Countries citing papers authored by Per Omvik

Since Specialization
Citations

This map shows the geographic impact of Per Omvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Omvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Omvik more than expected).

Fields of papers citing papers by Per Omvik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Omvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Omvik. The network helps show where Per Omvik may publish in the future.

Co-authorship network of co-authors of Per Omvik

This figure shows the co-authorship network connecting the top 25 collaborators of Per Omvik. A scholar is included among the top collaborators of Per Omvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Omvik. Per Omvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kjeldsen, Sverre E., Richard B. Devereux, Darcy A. Hille, et al.. (2009). Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study. Blood Pressure. 18(6). 348–361. 15 indexed citations
2.
Ibsen, Hans, Kristian Wachtell, Michael Hecht Olsen, et al.. (2004). Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. Journal of Hypertension. 22(9). 1805–1811. 96 indexed citations
3.
Kizer, Jorge R., Aud Høieggen, Michael H. Alderman, et al.. (2004). 812-4 Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) study. Journal of the American College of Cardiology. 43(5). A475–A475. 4 indexed citations
4.
Høieggen, Aud, Michael H. Alderman, Sverre E. Kjeldsen, et al.. (2004). The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney International. 65(3). 1041–1049. 368 indexed citations
5.
Omvik, Per, et al.. (2003). The Norwegian office-, home-, and ambulatory blood pressure study (NOHA). Blood Pressure. 12(4). 211–219. 17 indexed citations
6.
Kjeldsen, Sverre E., Björn Dahlöf, Richard B. Devereux, et al.. (2002). Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. JAMA. 288(12). 1491–1491. 302 indexed citations
7.
Timmermann, Bernd, Ran Mo, Friedrich C. Luft, et al.. (1998). β-2 Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney International. 53(6). 1455–1460. 122 indexed citations
8.
Omvik, Per. (1996). How smoking affects blood pressure. Blood Pressure. 5(2). 71–77. 169 indexed citations
9.
Gerdts, Eva, Einar Svarstad, Ole L. Myking, Per Lund‐Johansen, & Per Omvik. (1996). Salt Sensitivity in Hypertensive Type-1 Diabetes Mellitus. Blood Pressure. 5(2). 78–85. 18 indexed citations
10.
11.
Lund‐Johansen, Per, Per Omvik, & William B. White. (1994). Measurement of long-term hemodynamic changes and the use of 24-hour blood pressure monitoring to evaluate treatment. The American Journal of Cardiology. 73(3). A44–A49. 4 indexed citations
12.
Lund‐Johansen, Per & Per Omvik. (1993). Cardiac Effects of ACE Inhibition. Journal of Cardiovascular Pharmacology. 22. S36–40. 5 indexed citations
13.
14.
15.
16.
Lund‐Johansen, Per & Per Omvik. (1992). Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise. European Heart Journal. 13(2). 281–286. 14 indexed citations
17.
18.
Lund‐Johansen, P & Per Omvik. (1990). The role of multiple action agents in hypertension. European Journal of Clinical Pharmacology. 38(S2). S89–S95. 4 indexed citations
19.
Omvik, Per. (1990). Magnetic resonance imaging and cine computerized tomography as future tools for cardiac output measurement. European Heart Journal. 11(suppl I). 141–143. 6 indexed citations
20.
Chaignon, M, et al.. (1978). Hemodynamic studies in chronic hemodialysis patients with hemofiltration/ultrafiltration.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 24. 682–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Björn Dahlöf Breakdown of academic impact, for papers by Ole Lederballe‐Pedersen Breakdown of academic impact, for papers by W. H. Birkenhäger Breakdown of academic impact, for papers by Joël Ménard Breakdown of academic impact, for papers by Vasilios Papademetriou Breakdown of academic impact, for papers by Gastone Leonetti Breakdown of academic impact, for papers by Dag Elmfeldt Breakdown of academic impact, for papers by Enrico Agabiti‐Rosei Breakdown of academic impact, for papers by Carlo Porcellati Breakdown of academic impact, for papers by Björn Dahlöf
Rankless by CCL
2026